ArticleOncotarget2015

Cytogenomic profiling of breast cancer brain metastases reveals potential for repurposing targeted therapeutics.

Aliccia Bollig-Fischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.